The same proven GLP-1 science in a daily tablet - a needle-free alternative for patients who prefer oral medication over injections. Individual results may vary.
From $299/month
30 Day Money Back Guarantee
*Prescription required. Not all patients qualify. This is a compounded medication prepared by a licensed 503A pharmacy and is not an FDA-approved product.
Oral semaglutide is a GLP-1 receptor agonist delivered as a daily tablet. Our compounded version is prepared by a licensed 503A compounding pharmacy and is not an FDA-approved product. It works through the same proven GLP-1 pathway:
Take a simple daily tablet instead of weekly injections. Ideal for patients who are uncomfortable with needles or prefer the convenience of oral medication.
Oral semaglutide activates the same GLP-1 receptors as the injectable form, providing the same appetite-suppressing and metabolism-regulating benefits.
Acts on the brain's hunger centers to reduce cravings and food noise, helping you feel satisfied with smaller portions throughout the day.
Take one tablet daily on an empty stomach with a small sip of water. It integrates easily into your morning routine with minimal disruption.
Oral semaglutide follows a gradual dose escalation, similar to the injectable form, to help your body adjust and minimize side effects.
You begin with a low daily dose to let your body adjust. Most patients start noticing reduced appetite and fewer cravings within the first couple of weeks.
Your dose is increased incrementally. Consistent weight loss begins as the medication reaches therapeutic levels. You'll notice meaningful changes in your relationship with food. Individual results may vary.
At your maintenance dose, weight loss progresses steadily. The OASIS 1 trial showed oral semaglutide patients achieved up to 15.1% body weight reduction. Individual results may vary. Energy levels stabilize and daily habits improve.
Continued progress toward your target weight with ongoing provider support. The daily tablet routine becomes second nature as you maintain your healthier lifestyle. Individual results may vary.
For best results, follow these guidelines when taking your daily tablet:
These steps help ensure optimal absorption of the medication. Your provider will walk you through the complete dosing instructions when your treatment begins.
Side effects of oral semaglutide are similar to the injectable form and are generally mild to moderate, improving as your body adjusts.
Common side effects include:
Less common but serious side effects (contact your provider immediately):
Important Safety Information: Semaglutide may cause thyroid C-cell tumors. It is not known whether semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always discuss your full medical history with your provider.
Every DirectGLP oral semaglutide plan includes everything you need - no surprises.
Oral semaglutide uses the same active ingredient and works through the same GLP-1 pathway. In the OASIS 1 clinical trial, oral semaglutide produced a 15.1% reduction in body weight, and the OASIS 4 trial published in the New England Journal of Medicine showed a 13.6% reduction at a 25 mg dose over 64 weeks. Individual results may vary. Your provider will help determine the best option for your goals. This is a compounded medication prepared by a licensed 503A pharmacy and is not an FDA-approved product.
Many patients prefer oral semaglutide because it eliminates the need for needles, doesn't require refrigeration, is easier to travel with, and fits naturally into a daily pill routine. It's an excellent option if you're uncomfortable with injections or simply prefer the convenience of a tablet.
Semaglutide is a peptide that needs to be absorbed through your stomach lining. Food and beverages can interfere with this absorption. Taking it on an empty stomach with only a small sip of water ensures the medication works as effectively as possible.
Yes, your provider can help you transition between injectable and oral semaglutide if you'd like to switch. Dosing adjustments may be needed during the transition, and your provider will create a plan tailored to your situation.
Most patients notice appetite changes within the first 1-2 weeks. Measurable weight loss typically begins within 4-8 weeks as your dose is gradually increased. Individual results may vary based on starting weight, diet, and activity level.
Yes, unlike injectable semaglutide (which is once weekly), oral semaglutide is taken once daily. The daily dosing maintains consistent medication levels in your body for steady appetite control throughout the day.
Yes. All GLP-1 medications require a valid prescription from a licensed healthcare provider. During your online assessment, a provider will review your health history and determine if oral semaglutide is medically appropriate for you. Medication is only dispensed after provider approval.
Take our quick assessment to see if oral semaglutide is right for you.
Contact Us
Copyright © DirectGLP. All Rights Reserved